Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma.

Asif H Khan1 *, Cori Gray2 *, Laurent Eckert,1 Caroline Amand,1 Jaman Maroni,3 Zhixiao Wang,3 Bethan Jones,4 Thomas Berni,4 Christopher Ll Morgan,4 Paul J Rowe5 1Sanofi, Chilly-Mazarin, France; 2Sanofi, Cambridge, MA, USA; 3Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA; 4Pharmatelligence, Cardiff, UK; 5Sanofi, Bridgewater, NJ, USA*These authors contributed equally to this workCorrespondence: Asif H Khan, Sanofi, 1 Avenue Pierre Brossolette, Chilly-Mazarin, France, 91385, Tel +33160495076, Email Asif.Khan@sanofi.com